The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 18, 2006
Filed:
Mar. 31, 2004
Dale S. Dhanoa, Wakefield, MA (US);
Oren Becker, Mevaseret Zion, IL;
Silvia Noiman, Herzliya, IL;
Sekar A. Reddy, Woburn, MA (US);
Srinivasa Rao Cheruku, Woburn, MA (US);
Rosa E. Mele'ndez, Woburn, MA (US);
Anurag Sharadendu, Salem, NH (US);
Dongli Chen, Chestnut Hill, MA (US);
Yael Marantz, Kadima, IL;
Sharon Shachem, Alfey Menashe, IL;
Alexander Heifetz, Bnei-Brak, IL;
Boaz Inbal, Kfar Shmuel, IL;
Venkitasamy Kesavan, Woburn, MA (US);
Shay Bar-haim, Netanya, IL;
Dale S. Dhanoa, Wakefield, MA (US);
Oren Becker, Mevaseret Zion, IL;
Silvia Noiman, Herzliya, IL;
Sekar A. Reddy, Woburn, MA (US);
Srinivasa Rao Cheruku, Woburn, MA (US);
Rosa E. Mele'ndez, Woburn, MA (US);
Anurag Sharadendu, Salem, NH (US);
Dongli Chen, Chestnut Hill, MA (US);
Yael Marantz, Kadima, IL;
Sharon Shachem, Alfey Menashe, IL;
Alexander Heifetz, Bnei-Brak, IL;
Boaz Inbal, Kfar Shmuel, IL;
Venkitasamy Kesavan, Woburn, MA (US);
Shay Bar-Haim, Netanya, IL;
Predix Pharmaceuticals Holdings, Inc., Lexington, MA (US);
Abstract
The invention relates to 5-HT receptor antagonists. Novel piperidinylamino-thieno[2,3-d] pyrimidine compounds represented by Formula I, and synthesis and uses thereof for treating diseases mediated directly or indirectly by 5-HT receptors, are disclosed. Such conditions include central nervous system disorders such as anxiety, depression, schizophrenia, neural injury, stroke, and migraine. Methods of preparation and novel intermediates and pharmaceutical salts thereof are also included.